Your browser doesn't support javascript.
loading
Cytotoxic CD8+ T cells promote granzyme B-dependent adverse post-ischemic cardiac remodeling.
Santos-Zas, Icia; Lemarié, Jeremie; Zlatanova, Ivana; Cachanado, Marine; Seghezzi, Jean-Christophe; Benamer, Hakim; Goube, Pascal; Vandestienne, Marie; Cohen, Raphael; Ezzo, Maya; Duval, Vincent; Zhang, Yujiao; Su, Jin-Bo; Bizé, Alain; Sambin, Lucien; Bonnin, Philippe; Branchereau, Maxime; Heymes, Christophe; Tanchot, Corinne; Vilar, José; Delacroix, Clement; Hulot, Jean-Sebastien; Cochain, Clement; Bruneval, Patrick; Danchin, Nicolas; Tedgui, Alain; Mallat, Ziad; Simon, Tabassome; Ghaleh, Bijan; Silvestre, Jean-Sébastien; Ait-Oufella, Hafid.
Afiliação
  • Santos-Zas I; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Lemarié J; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Zlatanova I; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Cachanado M; Assistance Publique-Hôpitaux de Paris, APHP.SU; Department of Clinical Pharmacology and Clinical Research Platform (URCEST-CRB-CRC-EST), Hôpital Saint Antoine, Paris, France.
  • Seghezzi JC; Service de cardiologie, Centre Hospitalier de Compiegne, Compiegne, France.
  • Benamer H; Service de cardiologie, Institut Cardiovasculaire Paris Sud, Paris, France.
  • Goube P; Service de cardiologie, Centre Hospitalier de Corbeil, Corbeil, France.
  • Vandestienne M; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Cohen R; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Ezzo M; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Duval V; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Zhang Y; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Su JB; Inserm U955-IMRB, Equipe 03, UPEC, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
  • Bizé A; Inserm U955-IMRB, Equipe 03, UPEC, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
  • Sambin L; Inserm U955-IMRB, Equipe 03, UPEC, Ecole Nationale Vétérinaire d'Alfort, Maisons-Alfort, France.
  • Bonnin P; Inserm U965, Department of Physiology, Assistance Publique Hôpitaux de Paris, Hôpital Lariboisière, France.
  • Branchereau M; Inserm U1048-Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), université Paul Sabatier, Toulouse, France.
  • Heymes C; Inserm U1048-Institut des Maladies Métaboliques et Cardiovasculaires (I2MC), université Paul Sabatier, Toulouse, France.
  • Tanchot C; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Vilar J; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Delacroix C; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Hulot JS; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Cochain C; Institute of Experimental Biomedicine, University Hospital Würzburg, Würzburg, Germany.
  • Bruneval P; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Danchin N; Service d'anatomopathologie, Hôpital Europeen G. Pompidou, Assistance Publique, Hôpitaux de Paris, Paris, France.
  • Tedgui A; Service de cardiologie, Hôpital Europeen G. Pompidou, Assistance Publique, Hôpitaux de Paris, Paris, France.
  • Mallat Z; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Simon T; Université de Paris, PARCC, INSERM, F-75015, Paris, France.
  • Ghaleh B; Division of Cardiovascular Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 2QQ, UK.
  • Silvestre JS; Assistance Publique-Hôpitaux de Paris, APHP.SU; Department of Clinical Pharmacology and Clinical Research Platform (URCEST-CRB-CRC-EST), Hôpital Saint Antoine, Paris, France.
  • Ait-Oufella H; Sorbonne Université, UPMC-site St Antoine, Service de Pharmacologie, Assistance Publique-Hôpitaux de Paris, APHP.SU; Department of Clinical Pharmacology and Clinical Research Platform (URCEST-CRB-CRC-EST), Hôpital Saint Antoine, Paris, France.
Nat Commun ; 12(1): 1483, 2021 03 05.
Article em En | MEDLINE | ID: mdl-33674611
ABSTRACT
Acute myocardial infarction is a common condition responsible for heart failure and sudden death. Here, we show that following acute myocardial infarction in mice, CD8+ T lymphocytes are recruited and activated in the ischemic heart tissue and release Granzyme B, leading to cardiomyocyte apoptosis, adverse ventricular remodeling and deterioration of myocardial function. Depletion of CD8+ T lymphocytes decreases apoptosis within the ischemic myocardium, hampers inflammatory response, limits myocardial injury and improves heart function. These effects are recapitulated in mice with Granzyme B-deficient CD8+ T cells. The protective effect of CD8 depletion on heart function is confirmed by using a model of ischemia/reperfusion in pigs. Finally, we reveal that elevated circulating levels of GRANZYME B in patients with acute myocardial infarction predict increased risk of death at 1-year follow-up. Our work unravels a deleterious role of CD8+ T lymphocytes following acute ischemia, and suggests potential therapeutic strategies targeting pathogenic CD8+ T lymphocytes in the setting of acute myocardial infarction.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Remodelação Ventricular / Granzimas / Coração Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T CD8-Positivos / Remodelação Ventricular / Granzimas / Coração Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Male Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França